Results 81 to 90 of about 14,551 (185)

Myxoid liposarcoma of the porta hepatis in childhood

Liposarcoma in childhood is rare. A case of a myxoid liposarcoma arising at the porta hepatis is reported in a 3-year-old boy with initial favourable response to surgery combined with radio- and chemotherapy.
A. W., Craft, Wright, Skinner, N. B., R., R. E. J., Lee   +7 more
core   +5 more sources

Paratesticular myxoid liposarcoma in a 23-year old Nigerian

Rare Tumors, 2010
Paratesticular liposarcomas are rare tumors and are usually seen in patients in middle age or older. Optimal treatment is radical orchidectomy. Radiotherapy or chemotherapy is added for advanced disease or recurrences.
Okezie M. Mbadiwe, Ikenna I Nnnabugwu, Emeka F. Nnakenyi, Okechukwu C. Okafor, Fred O. Ugwumba   +4 more
doaj   +1 more source

Analysis of MDM2 and TP53 genes in canine liposarcoma

Scientific Reports
Canine liposarcoma is an uncommon tumor that shares morphological similarities with its human counterpart. In dogs, the genetic features of this tumor are unknown and, based on immunohistochemical studies, amplification of the gene MDM2 and the mutation ...
Luisa Vera Muscatello, Dario de Biase, Thais Maloberti, Enrico di Oto, Giovanni Tallini, Valeria Pellegrino, Barbara Bacci, Paola Roccabianca, Elvio Lepri, Luca Crippa, Giancarlo Avallone   +10 more
doaj   +1 more source

Prognostic Factors of Liposarcoma in Head and Neck

Zhongliu Fangzhi Yanjiu
ObjectiveTo explore the pathogenesis and prognostic factors of liposarcoma in the head and neck region, and simultaneously analyze the efficacy of different treatment regimens.
Shuo DING, Zhigang HUANG, Jugao FANG, Yang ZHANG, Lizhen HOU, Wei GUO, Gaofei YIN, Qi ZHONG   +7 more
doaj   +1 more source

Neoadjuvant radiotherapy for myxoid liposarcomas: Oncologic outcomes and histopathologic correlations

Acta Orthopaedica et Traumatologica Turcica, 2017
Objective: The aim of this study was to evaluate the histopathological features of primary extremity myxoid liposarcoma before and after neoadjuvant radiation therapy, and to evaluate the oncological outcomes of the patients.
Ahmet Salduz, Buğra Alpan, Natig Valiyev, Emre Özmen, Ayça İribaş, Fulya Ağaoğlu, Aysel Bayram, Bilge Bilgiç, Harzem Özger   +8 more
doaj   +1 more source

Isolated metastatic extremity liposarcoma to the liver, an uncommon and transient finding

World Journal of Surgical Oncology, 2008
Background Extremity liposarcomas can metastasize to different areas of the body but have rarely been demonstrated to metastasize to the liver. Due to the unusual occurrence of isolated metastatic extremity liposarcoma to the liver, the optimal treatment
Grobmyer Stephen R, Reith John D, Garces Christopher A, Hochwald Steven N   +3 more
doaj   +1 more source

MYXOID LIPOSARCOMA OF MALE BREAST- AN UNUSUAL PRESENTATION

, 2014
Myxoid Liposarcoma is the second most common type of Liposarcoma, representing 30-40 % of all Liposarcoma in the extremities, particularly the thighs.
Kazi Manzur Kzader, Syed Md Akram, Md. Yakub Ali, A. F. M. Anwar Hossain   +3 more
core  

Pleomorphic myxoid liposarcoma in an adolescent with Li-Fraumeni syndrome

, 2017
We present the case of a 15-year-old female with a right perineal mass that was found to be pleomorphic myxoid liposarcoma, a recently recognized, rare subtype of liposarcoma.
Thorson, Chad M, Sinclair, Tiffany J, Alvarez, Elysia, Tan, Serena, Spunt, Sheri L, Chao, Stephanie D   +5 more
core   +1 more source

Abstracts

Molecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Soft tissue uptake of 99mTc-MDP in a case of myxoid liposarcoma with breast metastasis

The Pan African Medical Journal, 2016
Breast metastasis arising from non mammary malignancy is very rare and occurs in malignant melanomas, sarcomas, lung cancers, ovarian tumors, renal and thyroid carcinomas.
Abdelhamid Biyi, Abderrahim Doudouh
doaj   +1 more source